YOLFTbeta
60

Shaanxi Meibang Pharmaceutical Group Co Ltd

605033 · SHG · Basic Materials / Agricultural Inputs

16.99CNY-0.35 (-2.02%)

Price History

Full chart

Market Stats

Previous Close17.34
Open17.30
Day Range16.96 – 17.44
52-Week Range15.81 – 34.51
Volume729.60K
Market Cap2.65B
P/E (TTM)41.70
Forward P/E0.00
EPS0.47
Dividend Yield0.77%
Beta0.41
50-Day Avg19.23
200-Day Avg20.89

About

Shaanxi Meibang Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research and development, production, sale, and agricultural technology promotion, and service of pesticide products in China and internationally. The company offers pesticides, plant nutrients, fungicides, insecticides, acaricides, herbicides, plant growth regulators, fertilizers, and microbial fertilizers. It is also involved in sale of agricultural machinery. The company was founded in 1998 and is headquartered in Xi'an, China.

Company Details

  • SectorBasic Materials
  • IndustryAgricultural Inputs
  • CEOMr. Tong Zhang
  • Employees1.12K
  • HeadquartersShiyang Industrial Park, Xi'an, China, 710018, China
  • Websitehttps://www.meibang.cn

Leadership

  • Mr. Tong ZhangGM & Director · b. 1993
  • Ms. Meixi HeAccounting Supervisor & CFO · b. 1967
  • Ms. Lijuan HanDeputy GM & Director · b. 1978
  • Mr. Mingyu QiaoDeputy General Manager · b. 1977
  • Ms. Aixiang ZhaoCompany Secretary · b. 1969

Financials

Income Statement

Currency: CNY2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue421.96M438.56M515.71M568.52M842.49M906.05M699.03M885.53M911.95M
Growth (%)-+3.93%+17.59%+10.24%+48.19%+7.54%-22.85%+26.68%+2.98%
Cost of Revenue273.05M283.44M325.49M368.03M532.38M528.82M478.04M654.14M599.62M
Gross Profit148.91M155.12M190.22M200.49M310.11M377.23M220.99M231.39M312.33M
Gross Margin35.29%35.37%36.89%35.27%36.81%41.63%31.61%26.13%34.25%
Operating Expense79.03M88.25M104.17M112.90M187.61M236.96M170.62M200.75M247.55M
Operating Income69.88M66.86M86.05M87.59M122.50M140.27M50.37M30.64M64.78M
Operating Margin16.56%15.25%16.69%15.41%14.54%15.48%7.21%3.46%7.10%
EBITDA79.59M79.92M98.63M100.79M154.74M168.93M83.79M58.30M85.42M
EBITDA Margin18.86%18.22%19.13%17.73%18.37%18.65%11.99%6.58%9.37%
Net Income61.22M59.33M76.26M78.73M125.74M145.09M57.56M36.86M48.66M
Net Income Margin14.51%13.53%14.79%13.85%14.93%16.01%8.23%4.16%5.34%
R&D26.35M26.93M39.52M51.36M63.81M80.04M58.53M74.33M84.93M
R&D as % of Total Revenue6.25%6.14%7.66%9.03%7.57%8.83%8.37%8.39%9.31%
Interest Expense3.78M5.22M3.88M939.09K3.43M1.09M506.87K9.48K396.35K
Interest Expense % of Total Revenue0.90%1.19%0.75%0.17%0.41%0.12%0.07%0.00%0.04%

Balance Sheet

Currency: CNY2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets509.66M585.78M665.97M785.87M1.46B1.56B1.69B1.86B2.07B
Total Liabilities329.23M309.40M295.34M336.50M496.43M474.14M577.84M737.37M915.09M
Total Equity180.43M276.37M370.63M449.37M966.95M1.09B1.11B1.12B1.15B
Cash43.21M70.27M207.74M199.41M254.39M318.25M481.17M267.86M338.24M
Total Debt49.00M27.00M40.04M59.90M27.05M105.57M1.00M72.00M-
Net Debt5.79M-43.27M-167.70M-139.51M-227.34M-212.68M-480.17M-195.86M-

Cash Flow

Currency: CNY2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow29.41M16.96M128.45M74.88M-108.75M126.41M334.79M280.40M229.36M
Investing Cash Flow-30.20M24.89M-22.90M-43.49M-251.92M-34.40M-117.18M-537.47M-
Financing Cash Flow-599.94K15.20M21.93M-59.70M350.59M41.84M-58.42M24.85M-
Capital Expenditure17.56M34.86M33.78M61.71M106.53M109.29M203.69M158.81M184.63M
Free Cash Flow11.85M-17.90M94.67M13.17M-215.28M17.12M131.10M121.59M44.74M
Dividends Paid3.60M3.58M2.07M699.04K3.29M25.69M29.74M28.24M24.09M
FCF to OCF40.28%-105.57%73.70%17.59%197.95%13.54%39.16%43.36%19.50%
Dividend Paid to FCF30.39%-20.00%2.19%5.31%-1.53%150.03%22.69%23.23%53.86%

Earnings

Report DateSep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023
EPS Estimate-------
EPS Actual-0.040.460.680.19-0.040.250.51
Surprise-------
Timing-------

Key Statistics & Ratios

Market Cap2.65B
Enterprise Value2.42B
Trailing P/E41.70
Forward P/E0.00
Price / Sales2.70
Price / Book2.22
EPS0.47
Book Value8.81
Revenue (TTM)981.56M
Gross Profit (TTM)334.29M
EBITDA106.22M
Profit Margin6.48%
Operating Margin5.84%
Return on Equity5.44%
Return on Assets2.35%
Shares Outstanding135.20M
Shares Float32.70M
Beta0.41
Dividend Yield0.77%
Dividend Rate0.15
Payout Ratio31.91%

Dividends

20262×
0.05Nov 10, 20260.10Jun 17, 2026
20252×
0.05Dec 10, 20250.10Jun 11, 2025
20242×
0.04Dec 19, 20240.15Jun 7, 2024
20231×
0.22Jun 8, 2023
20221×
0.19Jun 22, 2022